These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28177944)
1. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus. Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells. Zhang H; Jiang H; Chen L; Liu J; Hu X; Zhang H Eur J Pharmacol; 2018 Jan; 818():364-370. PubMed ID: 29126793 [TBL] [Abstract][Full Text] [Related]
3. [Metformin can reduce the risk of colorectal cancer]. Fransgård T; Gögenur I Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593 [TBL] [Abstract][Full Text] [Related]
4. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients. Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer. Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749 [TBL] [Abstract][Full Text] [Related]
6. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus. Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114 [TBL] [Abstract][Full Text] [Related]
7. Metformin and Colorectal Cancer - A Systematic Review. Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001 [TBL] [Abstract][Full Text] [Related]
8. Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes. Samuel VP; Dahiya R; Singh Y; Gupta G; Sah SK; Gubbiyappa SK; Chellappan DK; Dua K J Environ Pathol Toxicol Oncol; 2019; 38(2):133-141. PubMed ID: 31679276 [TBL] [Abstract][Full Text] [Related]
9. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer. Dimberg J; Shamoun L; Landerholm K; Wågsäter D World J Gastroenterol; 2022 May; 28(19):2148-2151. PubMed ID: 35664033 [TBL] [Abstract][Full Text] [Related]
10. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit. Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586 [TBL] [Abstract][Full Text] [Related]
11. Abnormal differentiation of intestinal epithelium and intestinal barrier dysfunction in diabetic mice associated with depressed Notch/NICD transduction in Notch/Hes1 signal pathway. Min XH; Yu T; Qing Q; Yuan YH; Zhong W; Chen GC; Zhao LN; Deng N; Zhang LF; Chen QK Cell Biol Int; 2014 Oct; 38(10):1194-204. PubMed ID: 24890925 [TBL] [Abstract][Full Text] [Related]
12. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway. Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025 [TBL] [Abstract][Full Text] [Related]
13. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients. Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714 [TBL] [Abstract][Full Text] [Related]
14. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948 [TBL] [Abstract][Full Text] [Related]
15. Sirt3 promotes the autophagy of HK‑2 human proximal tubular epithelial cells via the inhibition of Notch‑1/Hes‑1 signaling. Wang Y; Chang J; Wang ZQ; Li Y Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278469 [TBL] [Abstract][Full Text] [Related]
16. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathway. Zhang J; Yu K; Han X; Zhen L; Liu M; Zhang X; Ren Y; Shi J Mol Med Rep; 2018 Jan; 17(1):1321-1325. PubMed ID: 29115554 [TBL] [Abstract][Full Text] [Related]
17. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus. Saito A; Kitayama J; Horie H; Koinuma K; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N Cancer Sci; 2020 Nov; 111(11):4012-4020. PubMed ID: 32794612 [TBL] [Abstract][Full Text] [Related]
18. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438 [TBL] [Abstract][Full Text] [Related]
19. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells. Soylu H; Kırca M; Avcı S; Ozpolat B; Ustunel I Exp Mol Pathol; 2021 Apr; 119():104607. PubMed ID: 33482170 [TBL] [Abstract][Full Text] [Related]
20. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes. Chen CH; Lin CL; Hsu CY; Kao CH QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]